ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Ranbaxy Was Never the Exception

Responding to some of the criticisms in Anant Phadke’s review of Katherine Eban’s Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma, “Indian Pharma Fraud and Beyond” (EPW, 18 January 2020), this author, who is the protagonist of the book, contends that the review downplays the importance of critical drug testing and is too forgiving of the transgressions of the Indian pharma industry.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Updated On : 14th Feb, 2020

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top